Financhill
Buy
66

MSCI Quote, Financials, Valuation and Earnings

Last price:
$563.84
Seasonality move :
9.45%
Day range:
$556.89 - $566.00
52-week range:
$475.32 - $642.45
Dividend yield:
1.21%
P/E ratio:
38.76x
P/S ratio:
15.16x
P/B ratio:
--
Volume:
631.9K
Avg. volume:
510.1K
1-year change:
15.22%
Market cap:
$43.6B
Revenue:
$2.9B
EPS (TTM):
$14.55

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MSCI
MSCI
$744.5M $3.90 7.64% 21.53% $614.53
CME
CME Group
$1.7B $2.81 9.35% 22.71% $271.12
MCO
Moodys
$1.9B $3.54 0.15% 8.83% $501.35
MORN
Morningstar
$585.8M $2.06 5.94% 38.29% $338.33
NDAQ
Nasdaq
$1.2B $0.77 -29.86% 107.64% $84.00
VALU
Value Line
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MSCI
MSCI
$564.02 $614.53 $43.6B 38.76x $1.80 1.21% 15.16x
CME
CME Group
$289.00 $271.12 $104.1B 29.07x $1.25 3.63% 16.56x
MCO
Moodys
$479.32 $501.35 $86.2B 41.39x $0.94 0.75% 12.07x
MORN
Morningstar
$308.42 $338.33 $13B 34.65x $0.46 0.56% 5.75x
NDAQ
Nasdaq
$83.54 $84.00 $48B 37.97x $0.24 1.15% 6.20x
VALU
Value Line
$39.19 -- $368.9M 17.19x $0.33 3.13% 10.34x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MSCI
MSCI
126.71% 0.784 10.36% 0.75x
CME
CME Group
11.23% -0.019 3.58% 0.02x
MCO
Moodys
64.84% 1.456 8.14% 1.39x
MORN
Morningstar
33.31% 1.101 6.31% 1.00x
NDAQ
Nasdaq
44.68% 1.585 21.42% 0.44x
VALU
Value Line
-- 0.046 0.76% 3.39x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MSCI
MSCI
$609M $377M 30.82% -- 50.62% $268.9M
CME
CME Group
$1.4B $1.1B 11.8% 13.28% 78.34% $1.1B
MCO
Moodys
$1.4B $881M 19.14% 54.49% 46.21% $672M
MORN
Morningstar
$350.5M $114.1M 16.24% 25.24% 20.18% $58.8M
NDAQ
Nasdaq
$816M $576M 6.14% 11.5% 27.75% $614M
VALU
Value Line
$5.3M $1.6M 22.91% 22.91% 17.44% $6.7M

MSCI vs. Competitors

  • Which has Higher Returns MSCI or CME?

    CME Group has a net margin of 38.7% compared to MSCI's net margin of 58.22%. MSCI's return on equity of -- beat CME Group's return on equity of 13.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    MSCI
    MSCI
    81.66% $3.71 $3.6B
    CME
    CME Group
    87.41% $2.62 $30.5B
  • What do Analysts Say About MSCI or CME?

    MSCI has a consensus price target of $614.53, signalling upside risk potential of 8.96%. On the other hand CME Group has an analysts' consensus of $271.12 which suggests that it could fall by -6.19%. Given that MSCI has higher upside potential than CME Group, analysts believe MSCI is more attractive than CME Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    MSCI
    MSCI
    7 6 0
    CME
    CME Group
    4 7 0
  • Is MSCI or CME More Risky?

    MSCI has a beta of 1.328, which suggesting that the stock is 32.817% more volatile than S&P 500. In comparison CME Group has a beta of 0.451, suggesting its less volatile than the S&P 500 by 54.901%.

  • Which is a Better Dividend Stock MSCI or CME?

    MSCI has a quarterly dividend of $1.80 per share corresponding to a yield of 1.21%. CME Group offers a yield of 3.63% to investors and pays a quarterly dividend of $1.25 per share. MSCI pays 45.9% of its earnings as a dividend. CME Group pays out 101.66% of its earnings as a dividend. MSCI's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

  • Which has Better Financial Ratios MSCI or CME?

    MSCI quarterly revenues are $745.8M, which are smaller than CME Group quarterly revenues of $1.6B. MSCI's net income of $288.6M is lower than CME Group's net income of $956.2M. Notably, MSCI's price-to-earnings ratio is 38.76x while CME Group's PE ratio is 29.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MSCI is 15.16x versus 16.56x for CME Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
    CME
    CME Group
    16.56x 29.07x $1.6B $956.2M
  • Which has Higher Returns MSCI or MCO?

    Moodys has a net margin of 38.7% compared to MSCI's net margin of 32.48%. MSCI's return on equity of -- beat Moodys's return on equity of 54.49%.

    Company Gross Margin Earnings Per Share Invested Capital
    MSCI
    MSCI
    81.66% $3.71 $3.6B
    MCO
    Moodys
    74.48% $3.46 $10.7B
  • What do Analysts Say About MSCI or MCO?

    MSCI has a consensus price target of $614.53, signalling upside risk potential of 8.96%. On the other hand Moodys has an analysts' consensus of $501.35 which suggests that it could grow by 4.6%. Given that MSCI has higher upside potential than Moodys, analysts believe MSCI is more attractive than Moodys.

    Company Buy Ratings Hold Ratings Sell Ratings
    MSCI
    MSCI
    7 6 0
    MCO
    Moodys
    10 11 0
  • Is MSCI or MCO More Risky?

    MSCI has a beta of 1.328, which suggesting that the stock is 32.817% more volatile than S&P 500. In comparison Moodys has a beta of 1.385, suggesting its more volatile than the S&P 500 by 38.473%.

  • Which is a Better Dividend Stock MSCI or MCO?

    MSCI has a quarterly dividend of $1.80 per share corresponding to a yield of 1.21%. Moodys offers a yield of 0.75% to investors and pays a quarterly dividend of $0.94 per share. MSCI pays 45.9% of its earnings as a dividend. Moodys pays out 30.13% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MSCI or MCO?

    MSCI quarterly revenues are $745.8M, which are smaller than Moodys quarterly revenues of $1.9B. MSCI's net income of $288.6M is lower than Moodys's net income of $625M. Notably, MSCI's price-to-earnings ratio is 38.76x while Moodys's PE ratio is 41.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MSCI is 15.16x versus 12.07x for Moodys. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
    MCO
    Moodys
    12.07x 41.39x $1.9B $625M
  • Which has Higher Returns MSCI or MORN?

    Morningstar has a net margin of 38.7% compared to MSCI's net margin of 13.49%. MSCI's return on equity of -- beat Morningstar's return on equity of 25.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    MSCI
    MSCI
    81.66% $3.71 $3.6B
    MORN
    Morningstar
    60.23% $1.82 $2.4B
  • What do Analysts Say About MSCI or MORN?

    MSCI has a consensus price target of $614.53, signalling upside risk potential of 8.96%. On the other hand Morningstar has an analysts' consensus of $338.33 which suggests that it could grow by 9.7%. Given that Morningstar has higher upside potential than MSCI, analysts believe Morningstar is more attractive than MSCI.

    Company Buy Ratings Hold Ratings Sell Ratings
    MSCI
    MSCI
    7 6 0
    MORN
    Morningstar
    1 1 0
  • Is MSCI or MORN More Risky?

    MSCI has a beta of 1.328, which suggesting that the stock is 32.817% more volatile than S&P 500. In comparison Morningstar has a beta of 1.019, suggesting its more volatile than the S&P 500 by 1.868%.

  • Which is a Better Dividend Stock MSCI or MORN?

    MSCI has a quarterly dividend of $1.80 per share corresponding to a yield of 1.21%. Morningstar offers a yield of 0.56% to investors and pays a quarterly dividend of $0.46 per share. MSCI pays 45.9% of its earnings as a dividend. Morningstar pays out 18.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MSCI or MORN?

    MSCI quarterly revenues are $745.8M, which are larger than Morningstar quarterly revenues of $581.9M. MSCI's net income of $288.6M is higher than Morningstar's net income of $78.5M. Notably, MSCI's price-to-earnings ratio is 38.76x while Morningstar's PE ratio is 34.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MSCI is 15.16x versus 5.75x for Morningstar. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
  • Which has Higher Returns MSCI or NDAQ?

    Nasdaq has a net margin of 38.7% compared to MSCI's net margin of 18.9%. MSCI's return on equity of -- beat Nasdaq's return on equity of 11.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    MSCI
    MSCI
    81.66% $3.71 $3.6B
    NDAQ
    Nasdaq
    39.04% $0.68 $20.9B
  • What do Analysts Say About MSCI or NDAQ?

    MSCI has a consensus price target of $614.53, signalling upside risk potential of 8.96%. On the other hand Nasdaq has an analysts' consensus of $84.00 which suggests that it could grow by 0.55%. Given that MSCI has higher upside potential than Nasdaq, analysts believe MSCI is more attractive than Nasdaq.

    Company Buy Ratings Hold Ratings Sell Ratings
    MSCI
    MSCI
    7 6 0
    NDAQ
    Nasdaq
    6 5 0
  • Is MSCI or NDAQ More Risky?

    MSCI has a beta of 1.328, which suggesting that the stock is 32.817% more volatile than S&P 500. In comparison Nasdaq has a beta of 1.004, suggesting its more volatile than the S&P 500 by 0.362%.

  • Which is a Better Dividend Stock MSCI or NDAQ?

    MSCI has a quarterly dividend of $1.80 per share corresponding to a yield of 1.21%. Nasdaq offers a yield of 1.15% to investors and pays a quarterly dividend of $0.24 per share. MSCI pays 45.9% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MSCI or NDAQ?

    MSCI quarterly revenues are $745.8M, which are smaller than Nasdaq quarterly revenues of $2.1B. MSCI's net income of $288.6M is lower than Nasdaq's net income of $395M. Notably, MSCI's price-to-earnings ratio is 38.76x while Nasdaq's PE ratio is 37.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MSCI is 15.16x versus 6.20x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
    NDAQ
    Nasdaq
    6.20x 37.97x $2.1B $395M
  • Which has Higher Returns MSCI or VALU?

    Value Line has a net margin of 38.7% compared to MSCI's net margin of 57.58%. MSCI's return on equity of -- beat Value Line's return on equity of 22.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    MSCI
    MSCI
    81.66% $3.71 $3.6B
    VALU
    Value Line
    59.6% $0.55 $99M
  • What do Analysts Say About MSCI or VALU?

    MSCI has a consensus price target of $614.53, signalling upside risk potential of 8.96%. On the other hand Value Line has an analysts' consensus of -- which suggests that it could fall by --. Given that MSCI has higher upside potential than Value Line, analysts believe MSCI is more attractive than Value Line.

    Company Buy Ratings Hold Ratings Sell Ratings
    MSCI
    MSCI
    7 6 0
    VALU
    Value Line
    0 0 0
  • Is MSCI or VALU More Risky?

    MSCI has a beta of 1.328, which suggesting that the stock is 32.817% more volatile than S&P 500. In comparison Value Line has a beta of 1.073, suggesting its more volatile than the S&P 500 by 7.341%.

  • Which is a Better Dividend Stock MSCI or VALU?

    MSCI has a quarterly dividend of $1.80 per share corresponding to a yield of 1.21%. Value Line offers a yield of 3.13% to investors and pays a quarterly dividend of $0.33 per share. MSCI pays 45.9% of its earnings as a dividend. Value Line pays out 55.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MSCI or VALU?

    MSCI quarterly revenues are $745.8M, which are larger than Value Line quarterly revenues of $9M. MSCI's net income of $288.6M is higher than Value Line's net income of $5.2M. Notably, MSCI's price-to-earnings ratio is 38.76x while Value Line's PE ratio is 17.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MSCI is 15.16x versus 10.34x for Value Line. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
    VALU
    Value Line
    10.34x 17.19x $9M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for Jun 2

Regeneron Pharmaceuticals [REGN] is down 0.46% over the past day.

Buy
55
RGC alert for Jun 2

Regencell Bioscience Holdings [RGC] is down 10.27% over the past day.

Sell
42
AMBA alert for Jun 2

Ambarella [AMBA] is down 1.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock